Loading

Delivering to the 80%: Scaling Community-Level CAR-T Access

June 18, 2025
Breakout Session
Value‚ Patient Access and Reimbursement
While CAR-T therapies have revolutionized cancer treatment, access remains largely confined to major academic medical centers, limiting treatment availability for most eligible patients. Expanding delivery to community hospitals and regional oncology networks is critical to ensuring equitable access to these life-saving therapies. However, challenges such as FACT accreditation, provider readiness, and logistical hurdles have slowed progress. This session will explore scalable models for CAR-T therapy delivery beyond academic centers, focusing on hospital network expansion, regulatory enablement, and industry-provider collaboration. Experts from leading biopharma companies, provider networks, and accreditation bodies will share their experiences and strategies for accelerating access.

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS